Gene · 9700
Papers1,544
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,544
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The permissive binding theory of cancer. | Front Oncol | 2023 | 38023252 | PubTator, text mining | PubMed |
| Analysis of Nucleoporin 107 Overexpression and Its Association with Prognosis and Immune Infiltration in Lung Adenocarcinoma by Bioinformatics Methods. | Int J Gen Med | 2023 | 38021066 | PubTator, text mining | PubMed |
| UBE2C promotes malignancy of cutaneous squamous cell carcinoma. | Skin Res Technol | 2023 | 38009019 | PubTator, text mining | PubMed |
| Identifying the driver miRNAs with somatic copy number alterations driving dysregulated ceRNA networks in cancers. | Biol Direct | 2023 | 37993951 | PubTator, text mining | PubMed |
| Prognostic gene HLA-DMA associated with cell cycle and immune infiltrates in LUAD. | Clin Respir J | 2023 | 37972401 | PubTator, text mining | PubMed |
| Role of UBE2C in Brain Cancer Invasion and Dissemination. | Int J Mol Sci | 2023 | 37958776 | PubTator, text mining | PubMed |
| Identification of a Complex Karyotype Signature with Clinical Implications in AML and MDS-EB Using Gene Expression Profiling. | Cancers (Basel) | 2023 | 37958462 | PubTator, text mining | PubMed |
| Genomic instability and eye diseases. | Adv Ophthalmol Pract Res | 2023 | 37846358 | PubTator, text mining | PubMed |
| Molecular landscape and functional characterization of centrosome amplification in ovarian cancer. | Nat Commun | 2023 | 37845213 | PubTator, text mining | PubMed |
| Overexpression of FRA1 (FOSL1) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression. | Cells | 2023 | 37830558 | PubTator, text mining | PubMed |
| Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumors. | JCI Insight | 2023 | 37796616 | PubTator, text mining | PubMed |
| Mild replication stress causes premature centriole disengagement via a sub-critical Plk1 activity under the control of ATR-Chk1. | Nat Commun | 2023 | 37773176 | PubTator, text mining | PubMed |
| TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in Gliomas. | Biomolecules | 2023 | 37759698 | PubTator, text mining | PubMed |
| A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors. | Sci Rep | 2023 | 37758792 | PubTator, text mining | PubMed |
| Lymphoma in Border Collies: Genome-Wide Association and Pedigree Analysis. | Vet Sci | 2023 | 37756103 | PubTator, text mining | PubMed |
Virulence genes and plasmid replicon profiles of selected β-lactamase-producing Acinetobacter baumannii from orthopaedic patients and the environment in a tertiary referral hospital in Tanzania, East Africa. | J Hosp Infect | 2023 | 37729952 | PubTator, text mining | PubMed |
| Drug repurposing based on differentially expressed genes suggests drug combinations with possible synergistic effects in treatment of lung adenocarcinoma. | Cancer Biol Ther | 2023 | 37710391 | PubTator, text mining | PubMed |
| An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers. | Cancer Res Commun | 2023 | 37707389 | PubTator, text mining | PubMed |
| Correlation Between Serum ESPL1 and Hepatitis B Virus-related Hepatocellular Carcinoma Histological Grade: A Chinese Single-center Case-control Study. | Anticancer Res | 2023 | 37648308 | PubTator, text mining | PubMed |
| Host Soluble Factors Cause Changes in Staphylococcus epidermidis Antibiotic Susceptibility and Biofilm Formation Ability. | Pathogens | 2023 | 37624024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9700/papers?page=4